An Improved Solution to Combat Heart Failure

“Whisper” – catheter based pump

“Freedom” – wireless powered chronic implant

Motor controller

Latest News

Second Heart Assist Continues With Compelling Momentum and Data – Impressive Clinical Results

Second Heart Assist has completed another round of highly successful OUS case studies in South America. Through a series of planned studies, Second Heart Assist has again demonstrated high levels of safety and efficacy in the use of the “Whisper” device designed to uniquely support multiple indications of HF support including; HR-PCI, ADHF, and CS.

Second Heart Assist Announces Impressive Successful Trials in Central America with its Whisperâ„¢ Device

SALT LAKE CITY, July 25, 2024 /PRNewswire/ -- Utah-based Second Heart Assist Inc., announced today the successful completion of the company's first Central American case to evaluate the performance of its Whisperâ„¢ percutaneous mechanical circulatory device. The device...

Latest Advances in Treatment of CHF with Devices

In this episode, Zvonimir Krajcer, MD, William "Billy Cohn, MD, and Les Miller, Roubin, MD, discuss the history of ventricular assist devices and future directions of the field of mechanical circulatory support.   https://www.youtube.com/watch?v=OgYobicYCPU

CAUTION Disclaimer and Warning: Products described on this web site are in development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.